Human papillomavirus vaccine uptake in adolescents with developmental disabilities
Jenny O'Neill, Sonja Elia, Kirsten P Perrett
JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITY | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | Published : 2019
Background: The Human Papillomavirus (HPV) vaccine is offered in Australia to all males and females at 12 to 13 years. In 2015 the national HPV coverage was 77.4% for females and 66.4% for males. There is no Australian coverage data for the subgroup of adolescents with disabilities. Method: We reviewed the HPV vaccine status of all 14 year-old adolescents who attended a developmental medicine clinic in a tertiary hospital in Melbourne during 2014. Motor function and intellectual impairment were also recorded. Results: Of the 72 adolescents in the audit, only 39.5% of males and 44.1% of females were fully immunised against HPV. Those with intellectual impairment had particularly low levels of..View full abstract
Awarded by NHMRC Early Career Fellowship
KPP is supported by an NHMRC Early Career Fellowship (APP1054394) and a MRCI Career Development Award.